|Issuer:||VAXART, INC. (VXRT)|
|Original Submission Date:|
YEDID ROBERT A.
C/O VAXART, INC.
170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO, CA 94080
|Title of Security||Transaction Date||2a. Deemed Execution Date||Transaction Code||Shares||Acquired or Disposed||Price per share||5. Amount of Securities Beneficially Owned Following Reported Transaction||6. Ownership Form Direct or Indirect||Nature of Indirect Ownership|
|Title of Derivative Security||Conversion or Exercise Price of Derivative Security||Transaction Date||Deemed Execution Date||Transaction Code||Number of Derivative Securities Acquired (A) or Disposed of (D)||Date Exercisable||Expiration Date||Title and Amount of Securities Underlying Derivative Security||Price of Derivative Security||Number of derivative Securities Beneficially Owned Following Reported Transaction(s)||Ownership Form: Direct (D) or Indirect (I)||Nature of Indirect Beneficial Ownership|
|STOCK OPTION (RIGHT TO BUY)||0.31||2021-06-11||deemed execution date||M||18,240 (d)||2029-11-17||common stock 18,240||$0.31||36,480||direct|
|f1||the shares subject to this option shall vest annually over three years from the vesting commencement date of october 25, 2019, the date of the grantee's appointment as a director of vaxart, inc.|